Pulmonary symptoms measured by the National Institutes of Health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease

Authors

Jeanne Palmer, Medical College of Wisconsin
Kirsten M. Williams, George Washington UniversityFollow
Yoshihiro Imamoto, Fred Hutchinson Cancer Research Center, Seattle, WA
Xiaoyu Chai, Fred Hutchinson Cancer Research Center, Seattle, WA
Paul J. Martin, Fred Hutchinson Cancer Research Center, Seattle, WAFollow
David Jacobsohn, George Washington UniversityFollow
+13 additional authors

Document Type

Response or Comment

Publication Date

3-2014

Journal

Biology of Blood and Marrow Transplantation

Volume

Volume 20, Issue 3

Inclusive Pages

337-344

Keywords

Graft vs. Host Disease--physiopathology; Hematologic Neoplasms--therapy; Hematopoietic Stem Cell Transplantation; Lung--physiopathology; Patient Outcome Assessment

Comments

PMCID: PMC3973401 [Available on 2015/3/1]

APA Citation

Palmer, J., Williams, K., Inamoto, Y., Chai, X., Tomas, L.S. et al. (2014). Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation, 20(3), 337-344.

Peer Reviewed

1